Biostatistics in the new millennium: A consulting statistician's perspective

Statistical Methods in Medical Research

Volumn 9, Issue 1, 2000, Pages 3-16

  Gehan, Edmund A ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSTATISTICS; HEALTH STATISTICS; HISTORY; MATHEMATICAL COMPUTING; PREDICTION AND FORECASTING; REVIEW; STATISTICAL CONCEPTS; STATISTICAL MODEL; STATISTICAL PARAMETERS;

EID: 0034055295     PISSN: 09622802     EISSN: None     Source Type: Journal    
DOI: 10.1191/096228000675548936     Document Type: Review

References (58)

1. Armitage P, David HA. Advances in biometry: 50 years of the International Biometric Society. New York: John Wiley, 1996.
2. Zelen M. Biostatistical science as a discipline: a look into the future. Biometrics 1983; 39: 827-37.
3. Cox DR. Statistics, overview. In: Armitage P, Colton T eds. Encyclopedia of biostatistics. New York: John Wiley, 1998: 4294-302.
4. Brown BW. Biostatistics, overview. In: Armitage P, Colton T eds. Encyclopedia of biostatistics. New York: John Wiley, 1998: 389-98.
5. Matthews JR. History of biostatistics. In: Armitage P, Colton T eds. Encyclopedia of biostatistics. New York: John Wiley, 1998: 1931-36.
6. Van Houwelingen HC. The future of biostatistics: expecting the unexpected. Statistics in Medicine 1997; 16: 2773-84.
7. Louis T. Biostatistics and biostatisticians in the next millennium: a view from academe. Presented at the Joint Statistical Meetings, Baltimore, MD, August, 1999.
8. Hill AB. Memories of the British streptomycin trial in tuberculosis: the first randomized clinical trial. Controlled Clinical Trials 1990; 11: 77-79.
9. Kononen J, Bubendorf L, Kallioniemi A et al. Tissue microarrays for high-group molecular profiling of tumor specimens. Nature Medicine 1998; 4: 844-47.
10. Byar DP, Simon RM, Friedewald WT et al. Randomized clinical trials: perspectives on some recent ideas. New England Journal of Medicine 1976; 295: 74-80.
11. Wolmark N, Rockette H, Mamounas E et al. Clinical trials to assess the relative efficacy of fluorouracil and leucovorin, fluorouracil and levamisole, and fluorouracil, leucovorin and levamisole in patients with Duke's carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project C-4. Journal of Clinical Oncology 1999; 11: 3553-59.
12. Keating MJ, Gehan EA, Smith TL et al. A strategy for evaluation of new treatments in untreated patients: application to a clinical trial of AMSA for acute leukemia. Journal of Clinical Oncology 1987; 5: 710-21.
13. Holland PW. Statistics in causal inference [with discussion]. Journal of the American Statistical Association 1986; 81: 945-70.
14. Bankhead C. Debate swirls around the science of epidemiology. Journal of the National Cancer Institute 1999; 91: 1914-16.
15. Breslow N. Statistics in epidemiology: the case-control study. In: Armitage P, David HA eds. Advances in Biometry: 50 years of the International Biometric Society. New York: John Wiley, 1996: 287-318.
16. Cornfield J. A method of estimating comparative rates from clinical data. Applications to cancer of the lung, breast and cervix. Journal of the National Cancer Institute 1951; 11: 1269-75.
17. Doll R, Hill AB. Smoking and carcinoma of the lung. British Medical Journal 1950; 2: 739-48.
18. Correa A, Stewart WF, Yeh HC et al. Exposure measurement in case-control studies: reported methods and recommendations. Epidemiologic Reviews 1994; 16: 18-32.
19. Breslow N, Day NED. Statistical methods in cancer research. Vol II, The design and analysis of cohort studies. International Agency for Research on Cancer: Lyon, 1987.
20. Blot WJ, Chow WH, McLaughlin JK. Environmental epidemiology. In: Armitage P, Colton T eds. Encyclopedia of biostatistics. New York: John Wiley, 1998: 1318-30.
21. Lander ES, Waterman MS eds. Calculating the secrets of life. Washington, DC: National Academy Press, 1995.
22. Simon R. Introduction to statistical genomics, lecture notes for course delivered at International Society of Clinical Biostatistics Meeting, Heidelberg, Germany, September 1999.
23. Brandt EN. Risk assessment and public policy. In: Gordis L ed. Epidemiology and health risk assessment. Oxford: Oxford University Press, 1988: 275-80.
24. Feinleib M. History of health statistics. In: Armitage P, Colton T eds. Encyclopedia of biostatistics. New York: John Wiley, 1998: 1945-52.
25. Newcombe HB. Handbook of record linkage: records for health and statistical studies, administration and business. Oxford: Oxford University Press, 1988.
26. Smalls M, Kendrick S. Record linkage. In: Armitage P, Colton T eds. Encyclopedia of biostatistics. New York: John Wiley, 1998: 3745-50.
27. Chalmers I, Sackett D, Silagy C. The Cochrane collaboration. In: Maynard A, Chalmers I eds. Non-random reflections on health services research: on the 25th anniversary of Archie Cochrane's 'effectiveness and efficiency'. London: BMJ Books, 1997: 231-19.
28. Chalmers I. Cochrane collaboration. In: Armitage P, Colton T eds. Encyclopedia of biostatistics. New York: John Wiley, 1998: 764-67.
29. Cochrane AL. Effectiveness and efficiency. Random reflections on health services. London: Nuffield Provincial Hospitals Trust, 1972.
30. The Cochrane Library. The Cochrane database of systematic reviews. Oxford: The Cochrane Collaboration, 1996 (updated quarterly).
31. Snow J. On the mode of communication of cholera, 2nd edn. London: Churchill Livingstone, 1855.
32. Burkitt D, Wright DH. Burkitt's lymphoma. Edinburgh: Churchill Livingstone, 1970.
33. Anto JM, Sunyer J. Soya bean as a risk factor for epidemic asthma. In: Elliott P, Cusick J, English D, Stern R. Geographical and environmental epidemiology: methods for small area studies. Oxford: OUP for World Health Organization, 1992: 323-41.
34. Clayton DG, Kaldor J. Empirical Bayes estimates of age-standardized relative risks for use in disease mapping. Biometrics 1987; 43: 671-82.
35. Clayton DG, Bernardinelli L. Bayesian methods for mapping disease risk. In: Elliott P, Cusick J, English D, Stern R. Geographical and environmental epidemiology: methods for small area studies. Oxford: Oxford University Press, 1992: 205-20.
36. Wartenberg B, Greenberg M. Solving the cluster puzzle: clues to follow and pitfalls to avoid Statistics in Medicine 1993; 12: 1763-72.
37. Bithell JF. Geographical analysis. In: Armitage P, Colton T eds. Encyclopedia of biostatistics. New York: John Wiley, 1998: 1701-16.
38. Geisser S. The future of statistics in restrospect. In: Bernardo JM, DeGroot MH, Lindley DV, Smith AFM. Bayesian statistics, Vol 3. Oxford: Oxford University Press, 1988: 147-48.
39. Geisser S. On predicting observables: a selective update. In: Bernardo JM et al. eds. Bayesian statistics, Vol 2. Amsterdam: North-Holland, 1985: 203-30.
40. Cutler SJ, Greenhouse SW, Cornfield J et al. The role of hypothesis testing in clinical trials. Journal of Chronic Disease 1966; 19: 857-82.
41. Walker MD, Alexander E, Hunt WE. Evaluation of mithramycin in the treatment of anaplastic gliomas. Journal of Neurosurgery 1976; 44: 655-67.
42. Walker MD, Alexander E, Hunt WE et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. Journal of Neurosurgery 1978; 49: 333-43.
43. Spiegelhalter DJ, Freedman LS, Parmar MKB. Bayesian approaches to randomized trials. Journal of Royal Statistical Society A 1994; 157: 357-416.
44. Simon R. Optimal two-stage designs for Phase II clinical trials. Controlled Clinical Trials 1989; 10: 1-10.
45. Herndon JE. A design alternative for two-stage Phase II multicenter cancer clinical trials. Controlled Clinical Trials 1998; 19: 440-50.
46. Thall PF, Simon RM. Recent developments in the design of Phase II clinical trials. In: Thall P ed. Recent advances in clinical trial design and analysis. Boston, MA: Kluwer Publishers, 1995: 50-71.
47. Carlin BP, Louis PA. Empirical Bayes: past, present and future. Journal of the American Statistical Association 2000; in press.
48. Spiegelhalter DJ, Thomas A, Best N, Gilkes WR. BUGS: Bayesian inference using Gibbs sampling, Version 0.50. Technical Report, Medical Research Council Biostatistics Unit, Institute of Public Health, Cambridge University, 1995.
49. Breslow NE. Biostatistics and Bayes [with discussion]. Statistical Science 1990; 5: 269-98.
50. Audrain J, Lerman C, Liu A et al. Biobehavioral predictors of adolescent smoking. Transdisciplinary Tobacco Use Research Center, Georgetown University Medical Center, 1999.
51. Cox DR, Wermuth N. Multivariate dependencies: models, analysis and interpretation. London: Chapman & Hall, 1996.
52. Hastie T. Neural networks. In: Armitage P, Colton T eds. Encyclopedia of biostatistics. New York: John Wiley, 1998: 2986-89.
53. Nelder JA. Statistical computing. In: Armitage P, David HA eds. Advances in biometry: 50 years of the International Biometric Society. New York: John Wiley, 1996: 201-12.
54. Streitberg B. On the non-existence of expert systems - critical remarks on the artificial intelligence in statistics. Statistical Software Newsletter 1998; 14: 55-62.
55. Efron B, Tibshirani. Computer-intensive statistical methods. In: Armitage P, David HA eds. Advances in biometry: 50 years of the International Biometric Society. New York: John Wiley, 1996: 131-48.
56. Thompson EA. Statistical genetics. In: Armitage P, David HA eds. Advances in biometry: 50 years of the International Biometric Society. New York: John Wiley, 1996: 263-86.
57. Ellenberg JH. Statisicians' significance. Presidential address delivered to the American Statistical Association in Baltimore, MD on August 10, 1999. Journal of the American Statistical Association 2000; in press.
58. Henderson PH, Clarke JE, Woods, C. Summary report 1996; Doctors recipients from the United States Universities. Washington, DC: National Academy Press, 1998.